Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer – results from the HER-OS patient registry

Overview of attention for article published in BMC Cancer, November 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 7 news stories from 1 outlets.

Lucia est atteinte d’une forme agressive de cancer du sein appelée HER2 positif.

露西亚患有一种被称为人表皮生长因子受体2(HER2)蛋白质检测呈阳性的侵袭性乳腺癌。她始终在竭力获取一种名为“曲妥珠单抗”(Trastuzumab)的治疗药物，罗氏将这款药物命名为赫赛汀(Herceptin)并获批上市销售。多年以来，赫赛汀已在多个富裕国家获…

لوسيا مصابة بسرطان خبيث يُسمّى سرطان الثدي الإيجابي HER2. وتكافح لتحصل على تراستوزوماب؛ علاج تبيعه روش باسم هيرسيبتين ظلَّ على مد…

Lucía tiene una forma agresiva de cáncer de mama denominada HER2 positivo. Ha estado luchando por conseguir acceso a un…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 3 additional news stories.